Abbvie Inc Stock Performance
as on November 21, 2025 at 2:29 am IST
Day's Low
Day's High
$228$234.95
0.62%
Downside
2.41%
Upside
52 Week's Low
52 Week's High
$164.39$244.8128.35%
Downside
6.70%
Upside
Abbvie Inc share price movements today
- Previous Close
- $232.91
- Open
- $232.87
- Volume
- 2.7M
- Day's Low - High
- $228 - $234.95
- 52 Week Low - High
- $164.39 - $244.81
Abbvie Inc Historical Returns
- 1 Month Return
- + 0.37 %
- 3 Month Return
- + 11.36 %
- 1 Year Return
- + 38.84 %
- 3 Year Return
- + 50.28 %
- 5 Year Return
- + 130.97 %
Abbvie Inc Stock Fundamentals & Key Indicators
Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$413.3B
EPS (TTM)
10.6382
Dividend Yield
3.10%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
178.53
Industry PE ratio
18.176666666666666
PEG Ratio
0.4188
EBITDA
29.5B
Revenue (TTM)
59.6B
Profit Margin
4.00%
Return On Equity TTM
137.96%
Abbvie Inc Stock Valuation
Track how Abbvie Inc P/E has moved over time to understand its valuation trends.
Abbvie Inc in the last 5 years
Lowest (9.14x)
December 31, 2020
Industry (18.18x)
November 20, 2025
Today (178.53x)
November 20, 2025
Highest (18.93x)
March 31, 2025
Today’s Price to Earnings Ratio: 178.53x
Abbvie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $413.3B | 130.97% | 178.53 | 4.00% | |
| BUY | $923.4B | 621.42% | 50 | 30.99% | |
| BUY | $481.9B | 38.36% | 19.3 | 27.26% | |
| BUY | $240.9B | 18.15% | 12.76 | 29.63% | |
| BUY | $211.3B | 44.99% | 13.1 | 32.88% |
Stock Returns calculator for Abbvie Inc Stock including INR - Dollar returns
The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abbvie Inc investment value today
Current value as on today
₹1,41,932
Returns
₹41,932
(+41.93%)
Returns from Abbvie Inc Stock
₹36,761 (+36.76%)
Dollar Returns*
₹5,171 (+5.17%)
Analyst Recommendation on Abbvie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $243.55
Abbvie Inc Share Price Target
Get share price movements and forecasts by analysts on Abbvie Inc.
What analysts predicted
5.8%UPSIDE
Target Price
$243.55
Current Price
$229.43
Analyzed by
35 Analysts
Target
$243.55
Abbvie Inc target price $243.55, a slight upside of 5.8% compared to current price of $229.43. According to 35 analysts rating.
Abbvie Inc Stock’s Investor Sentiment and Interest
Investment in Abbvie Inc Shares on INDmoney has grown by 14.49% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:14.49% versus previous 30 day period
Search interest for Abbvie Inc Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:48% versus previous 30 day period
Abbvie Inc Quarterly Profit & Loss
All numbers in Millions USD
Abbvie Inc Annual Profit & Loss
All numbers in Millions USD
Abbvie Inc Quarterly Cash Flow
All numbers in Millions USD
Abbvie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Abbvie Inc Stock
Check out the Mutual Funds with significant holdings in Abbvie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 3.18231% | 2761 |
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.65894% | 13942 |
Global Institutional Holdings in Abbvie Inc
Abbvie Inc News & Key Events
Today's Timeline - 19 November
Wed, 07:38 PM
-AbbVie reports Q3 2025 results, beats estimates, but faces challenges with oncology drug sales and Humira's decline.
Wed, 08:25 PM
-FDA approves AbbVie's Epkinly for treating relapsed follicular lymphoma, marking a significant advancement in oncology.
Insights on Abbvie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Abbvie Inc has shown positive revenue growth over the last three quarters. The company's revenue increased from $13.34 billion to $15.77 billion, reflecting an average growth of 7.9% each quarter.
- POSITIVE IMPACT
Price Rise
In the last 1 year, ABBV stock has moved up by 38.8%
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly And Company has given 190.2% return, outperforming this stock by 139.9%
- NO EFFECT
Against Peers
In the last 1 year, Eli Lilly And Company has given 39.3% return, outperforming this stock by 0.5%
NEGATIVE IMPACTProfit Down
Abbvie Inc's net profit has decreased for the last three quarters, dropping from $1.28 billion to $186 million. This represents an average decline of 53.5% each quarter.
About Abbvie Inc
| Organisation | Abbvie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of Abbvie Inc
Name | Title |
|---|---|
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Dr. Roopal Thakkar M.D. | Executive VP of Research and Development & Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
FAQs
What is Abbvie Inc share price today?
Abbvie Inc share price today is $229.43 as on at the close of the market. Abbvie Inc share today touched a day high of $234.95 and a low of $228.
What is the 52 week high and 52 week low for Abbvie Inc share?
Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $164.39 on . Abbvie Inc stock price today i.e. is closed at $229.43,which is 6.28% down from its 52 week high and 39.56% up from its 52 week low.
What is Abbvie Inc's market capitalisation today?
Abbvie Inc market capitalisation is $0.41T as on .
How to invest in Abbvie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Abbvie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbvie Inc Shares that will get you 0.0065 shares as per Abbvie Inc share price of $229.43 per share as on November 21, 2025 at 2:29 am IST.
What is the minimum amount required to buy Abbvie Inc Stock (ABBV) from India?
Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹88.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.80 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbvie Inc share’s latest price of $229.43 as on November 21, 2025 at 2:29 am IST, you will get 0.0436 shares of Abbvie Inc. Learn more about
fractional shares .
What are the returns that Abbvie Inc has given to Indian investors in the last 5 years?
Abbvie Inc stock has given 130.97% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?